4 results
To establish the safety and effectiveness of the Sonata System in the treatment of symptomatic uterine fibroids.
The objectives of this study are (a) to train healthcare workers to use of the Medtronic Sentrino® system, and (b) to obtain feedback from healthcare workers on its usability.
To evaluate the long-term safety, tolerability and efficacy of ArikaceTM 590 mg for a maximum 12 cycles administered once daily, where each cycle consists of 28 days on treatment followed by 28 days off treatment.
Primary Objective1. To evaluate the efficacy of LAI (590 mg) administered once daily (QD), when added to a multi-drug regimen, for achieving culture conversion (3 consecutive monthly negative sputum cultures) by Month 6 compared to a multi-drug…